| 000 | 01390 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250518043731.0 | ||
| 264 | 0 | _c20191230 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1464-5246 | ||
| 024 | 7 |
_a10.1080/02652048.2019.1631401 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSanthosh, Shivalingappa | |
| 245 | 0 | 0 |
_aImproved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. _h[electronic resource] |
| 260 |
_bJournal of microencapsulation _cJun 2019 |
||
| 300 |
_a338-355 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aRisedronic Acid _xadministration & dosage |
| 700 | 1 | _aMukherjee, Dhrubojyoti | |
| 700 | 1 | _aAnbu, Jayaraman | |
| 700 | 1 | _aMurahari, Manikanta | |
| 700 | 1 | _aTeja, Banala Venkatesh | |
| 773 | 0 |
_tJournal of microencapsulation _gvol. 36 _gno. 4 _gp. 338-355 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/02652048.2019.1631401 _zAvailable from publisher's website |
| 999 |
_c29790112 _d29790112 |
||